• Newly revitalized and expanding Initiatives to Move Discoveries to Drugs and Diagnostics
• Established collaborations of unconventional combinations, with more in progress
• Winning concepts, new grants, patents and licenses
• Combinatorial chemistry; high throughput screening
• Molecular modeling and drug design
• Database development and mining
• ab initio molecular structure for defined functions
• Protein and steroid hormone mimics by design
• Cell surface characteristics, trafficking and signaling
• Sensitive receptor assays for assessing compound activities
• Expertise with peptides, carbohydrates, nucleic acids, lipids, and natural products
• Genomics, proteomics and metabolomics for assessing disease status and identifying molecular targets
• Industrial collaborations and  internships
• Unique IMD3 collection of compounds with diverse structures
• University fellowships and summer scholars program for multidisciplinary training
• IMD3 Symposium on contemporary topics
• Graduate student partnering and development; Fall Fest, travel awards and presentations
• Modern instrumentation for characterization and analysis

Current initiatives include establishing benchmarks for funding and publications, attracting additional industrial support, increasing patents and licensing opportunities, adding another endowed chair, designing a facility for a core synthesis and chemical collection storage and a chemoinformatics laboratory, and submitting a joint research proposal or training grant to a national funding agency.